Dr. Michael E. Klufas, MD

Dr. Klufas practices at Michael E. Klufas, MD in Cumberland, Rhode Island.

Dr. Klufas' NPI, 1205822277, was assigned on September 23, 2005. Dr. Klufas graduated from Universidad Autonoma de Guadalajara in 1983. Dr. Klufas holds Rhode Island license 6939.

Dr. Klufas' primary practice is Michael E. Klufas, MD, at 525 Broad St, Cumberland, RI 02864 in Providence County. The practice phone is (401) 726-1048.

Dr. Klufas' primary practice is Michael E. Klufas, MD in Cumberland, Rhode Island. Dr. Klufas is also affiliated with The Miriam Hospital. The medical group on file is Michael E Klufas MD. Dmand AI also links Dr. Klufas to 3 more hospitals, 5 skilled nursing facilities, 4 home health agencies, 4 hospices and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Klufas practices, 18 sites in all. Vendor and product names are available with a free account.

Geriatric medicine is Dr. Klufas' primary specialty in the NPI Registry, under taxonomy code 207RG0300X. Dr. Klufas is board certified in geriatric medicine by the American Board of Internal Medicine. Dmand AI has Dr. Klufas' licenses on file in 3 states: Rhode Island, New York and Maryland.

Dmand AI lists acid reflux, acute skin infection, alzheimer's disease, aneurysm, anxiety, arthritis, atrial fibrillation and flutter and bronchitis among the conditions Dr. Klufas treats.

CMS data shows 849 Medicare services from Dr. Klufas across 11 procedure codes in 2024, for 392 Medicare patients. Medicare paid $64,957 for them. Every service was in an office.

CMS counts 392 Medicare patients who saw Dr. Klufas in 2024. The largest group is 75 to 84, with 157 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Klufas' median patient age at 74, with 54% women.

In 2024, Dr. Klufas wrote 38,141 Medicare Part D claims for 1,155 patients. 81% of them were for generic drugs. CMS names the drug for 37,216 of them, across 315 drugs with 11 or more claims each, at $3,284,953 in total drug cost. In 2023, CMS named 36,689 claims across 319 drugs.

Dr. Klufas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Klufas as offering telehealth.

CMS Open Payments shows 2,467 general payments to Dr. Klufas from 76 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Janssen Pharmaceuticals, Inc paid the most, $5,442.

Dr. Klufas graduated from Universidad Autonoma de Guadalajara in 1983.

Dr. Klufas is in network with 16 carriers, including Elevance, Excellus BlueCross BlueShield and Aetna. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.